VYNE Therapeutics Inc.
NasdaqCM:VYNE
$ 2.77
$0.00 (0.00%)
$ 2.77
$0.00 (0.00%)
End-of-day quote: 05/17/2024

VYNE - VYNE Therapeutics Stock Prediction 2025 - 2030

4 years of reliable VYNE Therapeutics stock forecast. The Wall Street analysts predict Buy for VYNE. See at a glance whether NasdaqCM:VYNE will rise in the future.

$0.00
Forecast 2023
$3.29
Forecast 2025
$5.59
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$3.29
Forecast 2030
$5.59
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.48
Price-to-book Ratio
0.48
Market Cap
0.04B
TEV
-0.05 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$5.58

VYNE Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

VYNE Therapeutics Stock Forecast 2023

$5.75

In the last five quarters, VYNE Therapeutics’s Price Target has fallen from $62.98 to $5.58 - a -91.14% decrease. One analysts predict that VYNE Therapeutics’s share price will increase in the coming year, reaching $5.75. This would represent an increase of 3.05%.

107.58%
107.58
Last update: 05/20/2024

Highest Price Target $6.00

Average Price Target $5.75

Lowest Price Target $5.00

VYNE Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One VYNE Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $2.99. An increase of 7.87% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $3.02. An increase of 8.87% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $3.04. An increase of 9.86% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $3.07. An increase of 10.86% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $3.10. An increase of 11.86% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $3.13. An increase of 12.85% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $3.15. An increase of 13.85% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $3.18. An increase of 14.85% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $3.21. An increase of 15.84% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $3.24. An increase of 16.84% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $3.26. An increase of 17.84% compared to today's share price.

Stock Prediction for the Price of One VYNE Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $3.29. An increase of 18.83% compared to today's share price.

VYNE Therapeutics Stock Predictions 2030

VYNE Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $5.08. An increase of 83.33% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $5.13. An increase of 85.02% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $5.17. An increase of 86.72% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $5.22. An increase of 88.41% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $5.27. An increase of 90.1% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $5.31. An increase of 91.8% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $5.36. An increase of 93.49% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $5.41. An increase of 95.18% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $5.45. An increase of 96.88% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $5.50. An increase of 98.57% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $5.55. An increase of 100.26% compared to the previous month's estimate.

VYNE Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $5.59. An increase of 101.96% compared to the previous month's estimate.

P/E
0.00
Beta
1.48
Price-to-book Ratio
0.48
Market Cap
0.04B
TEV
-0.05 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$5.58

VYNE Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching VYNE Therapeutics Inc.?

The following analysts have recently covered VYNE Therapeutics:

H.C. Wainwright & Co.
LifeSci Capital, LLC
TD Cowen
(This information refers to the last 90 days.)

Who are the sell-side analysts watching VYNE Therapeutics Inc.?

The following sell-side analysts have recently covered VYNE Therapeutics:

Pantginis, Joseph
Ku, Stacy
Katkhuda, Rami Azeez
(This information refers to the last 90 days.)